Open AccessEffect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Author(s) -
Steven A. Yukl,
Amandeep Shergill,
Kenneth R. McQuaid,
Sara Gianella,
Harry Lampiris,
C. Bradley Hare,
Mark Pandori,
Elizabeth Sinclair,
Huldrych F. Günthard,
Marek Fischer,
Joseph K. Wong,
Diane V. Havlir
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32833ef7bb
Subject(s) - raltegravir , ileum , efavirenz , peripheral blood mononuclear cell , immunology , viral load , darunavir , rectum , medicine , gastroenterology , biology , human immunodeficiency virus (hiv) , antiretroviral therapy , biochemistry , in vitro
To determine whether raltegravir-containing antiretroviral therapy (ART) intensification reduces HIV levels in the gut.